2023 - Pharmacist Digest

STAT+: Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds

STAT

DECEMBER 12, 2024

During 2023, drugmakers substantially raised prices on five widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $815 million last year, according to a new report.

Drug Pricing

STAT+: Class action suit over UnitedHealth’s AI care denials nears key moment

STAT

FEBRUARY 7, 2025

It was first filed in 2023 after a series of STAT stories revealed the company’s practices. District Court in Minnesota, alleges that UnitedHealth and its subsidiary NaviHealth relied on flawed algorithms to cut off essential rehabilitative care to sick and injured Medicare Advantage beneficiaries.

Communication

Communication Hospitals

STAT+: UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care

STAT

APRIL 17, 2025

That is similar to what the company has been saying since June 2023. The higher use of care among these Medicare enrollees “was most notable within physician and outpatient services,” UnitedHealth said in its first-quarter earnings release.

Childhood vaccination coverage was falling across the globe even before Covid

STAT

JUNE 24, 2025

The study, which estimated childhood vaccination coverage between 1980 and 2023 in 204 countries and territories, found that the Covid-19 pandemic significantly intensified existing immunization challenges. Read the rest…

Vaccines

Vaccines Immunity Immunization

STAT+: FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues

STAT

APRIL 4, 2025

During an April 2023 inspection at Raptim facilites in Nava Mumbai, India, FDA inspectors found “objectionable conditions” that led them to conclude the company falsified data in testing for multiple subjects and samples across multiple studies, according to a letter sent last week to the pharmaceutical companies.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Opinion: FDA cuts may mean even less oversight of pet food

STAT

APRIL 4, 2025

The resulting pet food industry is massive — Americans spent $65 billion on pet food and treats in 2023 alone. More than 102 million U.S. households own a dog or a cat, and thousands more have fish, birds, or reptiles. Read the rest…

Opinion: Want to keep schools safe? Hire more nurses

STAT

FEBRUARY 6, 2025

Even worse, 9% of 9th through 12th graders attempted suicide in 2023, reflecting our nationwide teen mental health crisis. Youth depression has practically doubled over the past decade. Read the rest…

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT

OCTOBER 29, 2024

The first cycle of negotiations resulted in meaningful projected savings for Medicare and for people with Medicare — an estimated $6 billion for the program if the negotiated prices were in place in 2023 for the first 10 selected drugs, and $1.5

Drug Pricing

STAT+: Tennessee officials find Express Scripts violated law governing commercial pharmacy claims

STAT

APRIL 13, 2025

For the moment, the state has not fined the company, although it may yet do so, according to a consent order. A department spokesperson declined to comment. However, the audit was released two months after Express Scripts had been ordered to pay a $250,000 fine for failing to reimburse a pharmacy.

Specialty Pharmacies

Specialty Pharmacies Documentation Drug Pricing

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

MARCH 10, 2025

a nonprofit that drew $178 million in revenue in 2023, the latest year for which data are available, and spent half that money on marketing. Department of Agriculture and funded by dairy farmers and importers whose mission is to promote dairy consumption. It’s run by Dairy Management Inc.,

Mayo Clinic

Mayo Clinic Communication Hospitals

Opinion: The kids’ doctors aren’t all right

STAT

MARCH 19, 2025

In 2024, about 8% of pediatrics positions went unfilled , an increase from about 3% in 2023. It also tells the rest of us what fields of medicine are having trouble attracting new physicians. Meanwhile, children’s hospitals report large numbers of vacancies in many pediatric subspecialties. All

Hospitals

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

STAT

JANUARY 22, 2025

Merck’s Keytruda has been used against dozens of different cancers in millions of patients, making it the top-selling drug in the world, with over $25 billion in revenue in 2023. Opdivo, from Bristol Myers Squibb, earned $10 billion in 2023.

Immunity

Immunity Immunization Compounding Drug Development

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2

Express Pharma

JUNE 20, 2025

Media fill failures and weak investigations (Warning Letter – June 2023) An injectable manufacturing site in Telangana failed to simulate worst-case operational conditions in its aseptic process simulation (APS). Interventions such as extended line stoppage, component replenishment, and slow filling were excluded.

Documentation

Documentation Packaging Communication

A biopharma doubles down on diversity goals through a newly created position

PharmaVoice

JULY 1, 2025

The company’s pipeline includes other candidates aimed at IBS indications. “I I wanted to create a shared definition of patient centricity here at Ardelyx, and then weave that into the fabric of the organization."

Drug Development

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

JUNE 23, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.

Diabetes

Diabetes Packaging Biosimilars

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Inpatient Compounding Pharmacies

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Vaccines Immunity Immunization

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

European Pharmaceutical Review

JUNE 19, 2025

Interinstitutional File: 2023/0131 (COD). Proposal For a Regulation Of The European Parliament And Of The Council Laying Down Union Procedures For The Authorisation And Supervision Of Medicinal Products For Human Use And Establishing Rules Governing The European Medicines Agency – Mandate For Negotiations With The European Parliament.

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies

CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals GlobalData

Express Pharma

JUNE 24, 2025

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) disorders have seen a remarkable 339 per cent increase in licensing agreement deal value, rising from $640 million in 2023 to $2.81 billion in 2024, according to GlobalData.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Turbo-charge community pharmacy to save A&E millions of hours, says NPA

The Pharmacist

JUNE 28, 2025

The NPA’s analysis of NHS England data into conditions treated in A&E in 2023/24 found that 325,000 people had visited A&E with a sore throat or a […] The post Turbo-charge community pharmacy to save A&E millions of hours, says NPA appeared first on The Pharmacist.

Community Pharmacies

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

Express Pharma

JUNE 19, 2025

In FY 2023, India accounted for approximately 27 per cent of all FDA foreign drug inspections, with a notable proportion focused on sterile manufacturing sites. According to the U.S. FDA’s Foreign Inspections Dashboard, India consistently ranks as the most frequently inspected country outside the United States. References: 1.

Documentation

Documentation Vaccines Pharmaceutical Companies Pharmaceutical Companies

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management

EC grants orphan drug status to JR-446 for MPS IIIB

Pharmaceutical Business Review

JUNE 25, 2025

In September 2023, both companies formalised their partnership through a licensing agreement enabling Medipal to market JR-446 across regions outside Japan. IZCARGO (pabinafusp alfa), another product developed from this technology platform, has already received approval in Japan for treating a lysosomal storage disorder.

NICE recommends innovative cystic fibrosis therapy

European Pharmaceutical Review

JULY 15, 2025

The European Commission granted an expanded indication for Kaftrio in combination with ivacaftor in 2023. NICE’s decision about the once-daily triple therapy comes one year after its approval of Kaftrio ®. NICE’s present recommendation of Alyftrek follows its comparative assessment between Alyftrek and Kaftrio.

MHRA approves first oral treatment for hereditary angioedema attacks

Pharma Times

JULY 15, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacy Times

JUNE 25, 2025

This phase 1b clinical trial, conducted between September 2023 and November 2024, was designed to build on promising preclinical data that demonstrated improved efficacy and tolerability with continuous SC lenalidomide delivery in murine MM models.

Pharmacy Technician

Pharmacy Technician Immunity Immunization Diabetes

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacy Times

JUNE 23, 2025

The retrospective cohort study included all patients who met the criteria for the Medicare HRRP COPD model discharged between May 2021 and August 2023. The researchers included 187 patients and 92 patients in the pre- and postimplementation groups, respectively.

Pharmacy Technician

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 12, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Pharmacy Times

JUNE 19, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes

Pharmacies Need Strategies to Improve Health Care Access

Pharmacy Times

JUNE 18, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Immunity Immunization

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacy Times

JUNE 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management

Pharmacists Can Provide Travel Health Tips for Patients

Pharmacy Times

JUNE 25, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Medication Therapy Management (MTM) Vaccines Diabetes

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

Pharmacy Times

JULY 8, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Immunity Immunization Compounding Pharmacies

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Pharmacy Times

JULY 16, 2025

November 21, 2023. Spillover From an Intervention on Antibiotic Prescribing for Family Physicians. JAMA Network. 2025) doi:10.1001/jamanetworkopen.2025.18261 2025.18261 2. Antimicrobial Resistance. World Health Organization. News release. Accessed July 16, 2025.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management

Sheffield scientists and AstraZeneca develop new machine learning model for inverse protein folding

Express Pharma

JUNE 17, 2025

That research also appeared in Nature Machine Intelligence and became one of its most cited papers in 2023. The study builds on prior work between the University of Sheffield and AstraZeneca, including the development of DrugBAN, an AI model that predicts drug-target binding.

Drug Development

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

The Online Pharmacy Market Growing at 16.8% Per Year

pharmacy mentor

JUNE 16, 2025

between 2023 and 2030, according to GrandView Research. A Global Surge: Online Pharmacies on the Rise The global ePharmacy market was valued at approximately USD 60.0 billion in 2022, and forecasts indicate it will expand at a compound annual growth rate (CAGR) of 20.4% billion, with projections of reaching USD 505.36 billion by 2032.

Online Pharmacies

Online Pharmacies Customer Service People Management Packaging

The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

Drug Channels

JUNE 16, 2025

For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty pharmacies reached $683 billion, up 9% from the 2023 figure. It’s the 16th edition of our popular and comprehensive examination of the entire U.S. drug pricing, reimbursement, and dispensing system.

Specialty Pharmacies

Specialty Pharmacies Drug Pricing

3 of the year’s most notable FDA nods

PharmaVoice

JUNE 27, 2025

Of the 13 antibiotics OK’d for the market between mid-2017 and 2023, only two belonged to a new class of drugs, the WHO reported last year. The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion.

Vaccines

Vaccines Dosage Packaging Immunity

UTIs rack up £604m hospital bill in 2023-24

The Pharmacist

JULY 15, 2025

Treatment of urinary tract infections (UTIs) cost NHS hospitals in England an estimated £604m in 2023-24, according to the UK Health Security Agency (UKHSA).

Hospitals

STAT+: Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds

STAT+: Class action suit over UnitedHealth’s AI care denials nears key moment

Trending Sources

STAT+: UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care

Childhood vaccination coverage was falling across the globe even before Covid

STAT+: FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues

Opinion: FDA cuts may mean even less oversight of pet food

Opinion: Want to keep schools safe? Hire more nurses

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT+: Tennessee officials find Express Scripts violated law governing commercial pharmacy claims

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

Opinion: The kids’ doctors aren’t all right

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2

A biopharma doubles down on diversity goals through a newly created position

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Osivax publishes phase 2a results supporting dual flu vaccine approach

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals GlobalData

Turbo-charge community pharmacy to save A&E millions of hours, says NPA

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

EC grants orphan drug status to JR-446 for MPS IIIB

NICE recommends innovative cystic fibrosis therapy

MHRA approves first oral treatment for hereditary angioedema attacks

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Pharmacies Need Strategies to Improve Health Care Access

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacists Can Provide Travel Health Tips for Patients

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Sheffield scientists and AstraZeneca develop new machine learning model for inverse protein folding

Flu Vaccines Are a Go

The Online Pharmacy Market Growing at 16.8% Per Year

The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

3 of the year’s most notable FDA nods

UTIs rack up £604m hospital bill in 2023-24

Stay Connected